S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 812 JPY 2.65% Market Closed
Market Cap: ¥73.5B

Operating Margin

-29.6%
Current
Declining
by 7.6%
vs 3-y average of -22%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-29.6%
=
Operating Income
¥-8.5B
/
Revenue
¥28.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-29.6%
=
Operating Income
¥-8.5B
/
Revenue
¥28.7B

Peer Comparison

Country Company Market Cap Operating
Margin
JP
Sosei Group Corp
TSE:4565
73.5B JPY
Loading...
US
Eli Lilly and Co
NYSE:LLY
978.7B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.8B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
273B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
150.2B USD
Loading...
FR
Sanofi SA
PAR:SAN
95.7B EUR
Loading...

Market Distribution

Lower than 96% of companies in Japan
Percentile
4rd
Based on 6 730 companies
4rd percentile
-29.6%
Low
-125 500% — 4.2%
Typical Range
4.2% — 10.6%
High
10.6% — 9 743.7%
Distribution Statistics
Japan
Min -125 500%
30th Percentile 4.2%
Median 7%
70th Percentile 10.6%
Max 9 743.7%

Sosei Group Corp
Glance View

Market Cap
73.5B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Sosei Group Corp Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-29.6%
=
Operating Income
¥-8.5B
/
Revenue
¥28.7B
What is Sosei Group Corp's current Operating Margin?

The current Operating Margin for Sosei Group Corp is -29.6%, which is below its 3-year median of -22%.

How has Operating Margin changed over time?

Over the last 3 years, Sosei Group Corp’s Operating Margin has decreased from 45.9% to -29.6%. During this period, it reached a low of -81.9% on Dec 31, 2023 and a high of 45.9% on Sep 30, 2022.

Back to Top